Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BEVA monitoring shortage of equine influenza vaccinations
"If it becomes necessary, we will collectively work to devise practical solutions for dealing with any supply difficulties" - Jim Eyre, CEO of British Equestrian.
Equine organisations preparing to quantify impact of interrupted supply.

A collaboration between the British Equine Veterinary Association (BEVA), British Equestrian (BEF) and the British Horseracing Authority (BHA) has been set up to monitor interruptions to the supply of equine influenza vaccines.

Minor interruptions to the supply of vaccines have already been noted by the group, but a significant logistical issue faced by Boehringer Ingelheim has further raised the likelihood of a reduction in supplies in the months ahead. 

The group is liaising with the three vaccine manufacturers to create solutions and minimise the impact of the shortage. 

Chair of BEVA's Health and Medicines Committee, David Rendle said: “BEVA, BHA and the BEF will continue to work together with other industry and equestrian sporting bodies to manage the situation should the availability of influenza vaccines be compromised further.

“We remind all horse owners of the importance of maintaining vaccination for equine influenza but would advise they wait until as close a time as possible until their horse’s next dose is due to minimise current demand.”

Marc Laemmer, equine business head at Boehringer Ingelheim Animal Health, said: “We are currently experiencing a European-wide supply issue relating to our equine influenza and influenza-tetanus vaccines. 

“This has been caused by unexpected issues following the implementation of a technology upgrade and is not a product or quality issue. This means that some vet practices will have difficulty obtaining sufficient influenza vaccines and there may be a shortage in the UK market. 

“We understand the importance of these vaccines to equine welfare, and we are continuing to work tirelessly to find a solution so that we can return to normal supply as soon as possible.”

Become a member or log in to add this story to your CPD history

Strangles survey seeks views of horse owners

News Story 1
 With Strangles Awareness Week just around the corner (5-11 May), vets are being encouraged to share a survey about the disease with their horse-owning clients.

The survey, which has been designed by Dechra, aims to raise awareness of Strangles and promote best practices to prevent its transmission. It includes questions about horse owners' experiences of strangles, together with preventative measures and vaccination.

Respondents to the survey will be entered into a prize draw to win two VIP tickets to Your Horse Live 2025. To access the survey, click here 

Click here for more...
News Shorts
DAERA to reduce BVD 'grace period'

DAERA has reminded herd keepers of an upcoming reduction to the 'grace period' to avoid BVD herd restrictions.

From 1 May 2025, herd keepers will have seven days to cull any BVD positive or inconclusive animals to avoid restrictions being applied to their herd.

It follows legislation introduced on 1 February, as DAERA introduces herd movement restrictions through a phased approach. Herd keepers originally had 28 days to cull BVD positive or inconclusive animals.

DAERA says that, providing herd keepers use the seven-day grace period, no herds should be restricted within the first year of these measures.

Additional measures, which will target herds with animals over 30 days old that haven't been tested for BVD, will be introduced from 1 June 2025.

More information is available on the DAERA website.